Breaking News Instant updates and real-time market news.

MDXG

MiMedx

$7.12

-0.15 (-2.06%)

17:53
03/15/18
03/15
17:53
03/15/18
17:53

Piper suspends MiMedx rating, says DOJ review too much to digest

Piper Jaffray analyst Matt O'Brien suspended his rating and price target on MiMedx Group after the company disclosed that the Department of Justice is reviewing matters in parallel with an SEC investigation. The analyst, up until tonight, had an Overweight rating on MiMedx with an $18 price target. The stock closed the trading day down 15c to $7.12. "We have been standing by MiMedx in recent months despite numerous short selling reports on the company," O'Brien tells investors in a research note. He says, however, that the Department of Justice review, which is added to an Audit Committee and SEC investigation regarding the company's sales and distribution practices, is "simply too much for us to digest at the moment."

  • 05

    Apr

  • 29

    May

MDXG MiMedx
$7.12

-0.15 (-2.06%)

02/23/18
CHLM
02/23/18
NO CHANGE
Target $19
CHLM
Buy
MiMedx fundamentals, execution should ultimately 'win out,' says Craig-Hallum
Craig-Hallum analyst Matt Hewitt noted that MiMedx management hosted an update call to address investor concerns about the recently announced investigation into sales practices and accounting, during which they revealed that King & Spalding has been hired as an independent legal advisor and KPMG will provide forensic accounting services. Uncertainty surrounding the investigation and recent short seller attacks have pushed shares over 50% off of their highs, but Hewitt ultimately thinks the company's fundamentals and strong execution will "win out," making the stock "intriguing" at current levels, he tells investors. He keeps a Buy rating and $19 price target on MiMedx shares.
02/23/18
LSCM
02/23/18
DOWNGRADE
LSCM
Hold
MiMedx downgraded to Hold from Buy at Lake Street
02/23/18
02/23/18
DOWNGRADE
Target $9

Hold
MiMedx downgraded to Hold with $9 price target at Lake Street
As previously reported, Lake Street analyst Bruce Jackson downgraded MiMedx to Hold from Buy, stating that a resolution of the investigation into current and prior period sales and distribution practices is unlikely to be swift and the shares are unlikely to outperform until the investigation is resolved. If the investigation resolves favorably, the upside potential "would be significant and he would be an aggressive buyer of the stock, but for now Jackson cut his price target on MiMedx shares to $9 from $12.
02/27/18
CHLM
02/27/18
NO CHANGE
Target $19
CHLM
Buy
Craig-Hallum maintains Buy rating, $19 price target on MiMedx
Craig-Hallum analyst Matt Hewitt noted that MiMedx denied a report that it is under investigation by the Department of Justice, stating that it is not aware of any such investigation. While stating that "it is impossible to know for certain whether any nefarious activity has ever taken place at MiMedx," Hewitt points to several events over the past year that give him confidence in the integrity of the company's financials. If the company's financials are sound, he estimate that the stock is worth two and a half times the current price, added Hewitt, who keeps a Buy rating and $19 price target on MiMedx shares.

TODAY'S FREE FLY STORIES

RYCEY

Rolls-Royce

$0.00

(0.00%)

05:20
06/18/18
06/18
05:20
06/18/18
05:20
Upgrade
Rolls-Royce rating change  »

Rolls-Royce upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ASBFY

Associated British Foods

$0.00

(0.00%)

05:18
06/18/18
06/18
05:18
06/18/18
05:18
Upgrade
Associated British Foods rating change  »

Associated British Foods…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ACGL

Arch Capital

$80.43

-0.69 (-0.85%)

05:16
06/18/18
06/18
05:16
06/18/18
05:16
Initiation
Arch Capital initiated  »

Arch Capital initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RNR

RenaissanceRe

$123.82

-0.33 (-0.27%)

05:15
06/18/18
06/18
05:15
06/18/18
05:15
Initiation
RenaissanceRe initiated  »

RenaissanceRe initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WRB

W. R. Berkley

$75.33

0.06 (0.08%)

05:14
06/18/18
06/18
05:14
06/18/18
05:14
Initiation
W. R. Berkley initiated  »

W. R. Berkley initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RE

Everest Re

$226.37

0.38 (0.17%)

05:13
06/18/18
06/18
05:13
06/18/18
05:13
Initiation
Everest Re initiated  »

Everest Re initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AJG

Arthur J. Gallagher

$65.82

-0.17 (-0.26%)

05:13
06/18/18
06/18
05:13
06/18/18
05:13
Initiation
Arthur J. Gallagher initiated  »

Arthur J. Gallagher…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KNSA

Kiniksa

$18.28

-0.52 (-2.77%)

05:12
06/18/18
06/18
05:12
06/18/18
05:12
Initiation
Kiniksa initiated  »

Kiniksa initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Jun

GSKY

GreenSky

$24.27

-0.18 (-0.74%)

05:11
06/18/18
06/18
05:11
06/18/18
05:11
Initiation
GreenSky initiated  »

GreenSky initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NSRGY

Nestle

$0.00

(0.00%)

, XPO

XPO Logistics

$113.89

2.225 (1.99%)

05:11
06/18/18
06/18
05:11
06/18/18
05:11
Hot Stocks
Nestle, XPO Logistics co-creating 638,000-square-foot distribution center in UK »

Nestle (NSRGY) and XPO…

NSRGY

Nestle

$0.00

(0.00%)

XPO

XPO Logistics

$113.89

2.225 (1.99%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GPN

Global Payments

$117.51

-0.24 (-0.20%)

05:09
06/18/18
06/18
05:09
06/18/18
05:09
Downgrade
Global Payments rating change  »

Global Payments…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EVOP

EVO Payments

$22.98

0.95 (4.31%)

05:05
06/18/18
06/18
05:05
06/18/18
05:05
Initiation
EVO Payments initiated  »

EVO Payments initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CB

Chubb

$130.91

0.81 (0.62%)

05:04
06/18/18
06/18
05:04
06/18/18
05:04
Downgrade
Chubb rating change  »

Chubb downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LDOS

Leidos

$60.17

-0.585 (-0.96%)

05:02
06/18/18
06/18
05:02
06/18/18
05:02
Downgrade
Leidos rating change  »

Leidos downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RDFN

Redfin

$24.00

-0.64 (-2.60%)

, ZG

Zillow

$65.24

0.45 (0.69%)

05:00
06/18/18
06/18
05:00
06/18/18
05:00
Downgrade
Redfin, Zillow rating change  »

Redfin downgraded to Sell…

RDFN

Redfin

$24.00

-0.64 (-2.60%)

ZG

Zillow

$65.24

0.45 (0.69%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ZG

Zillow

$65.24

0.45 (0.69%)

04:58
06/18/18
06/18
04:58
06/18/18
04:58
Downgrade
Zillow rating change  »

Zillow downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EVRG

Evergy

$52.75

0.8 (1.54%)

04:55
06/18/18
06/18
04:55
06/18/18
04:55
Conference/Events
Evergy management to meet with Wolfe Research »

Wolfe Utilities Analyst…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jun

MDT

Medtronic

$86.78

0.2 (0.23%)

04:55
06/18/18
06/18
04:55
06/18/18
04:55
Conference/Events
Medtronic management to meet with JPMorgan »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jun

  • 19

    Jun

  • 20

    Jun

  • 25

    Jun

  • 26

    Jun

  • 12

    Jul

UPLD

Upland Software

$35.30

0.04 (0.11%)

04:55
06/18/18
06/18
04:55
06/18/18
04:55
Conference/Events
Upland Software management to meet with Craig Hallum »

Meeting to be held in Los…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jun

  • 26

    Jun

NUVA

NuVasive

$55.27

0.49 (0.89%)

04:55
06/18/18
06/18
04:55
06/18/18
04:55
Conference/Events
NuVasive management to meet with Piper Jaffray »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jun

  • 19

    Jun

  • 19

    Jun

  • 20

    Jun

  • 20

    Jun

  • 21

    Jun

  • 22

    Jun

  • 22

    Jun

  • 25

    Jun

  • 26

    Jun

  • 12

    Jul

WMGI

Wright Medical

$25.83

-0.26 (-1.00%)

04:55
06/18/18
06/18
04:55
06/18/18
04:55
Conference/Events
Wright Medical management to meet with Leerink »

Meeting to be held on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jun

  • 19

    Jun

  • 20

    Jun

  • 25

    Jun

  • 26

    Jun

  • 12

    Jul

BR

Broadridge

$114.93

0.06 (0.05%)

, RRC

Range Resources

$15.96

-0.19 (-1.18%)

04:55
06/18/18
06/18
04:55
06/18/18
04:55
Hot Stocks
Breaking Hot Stocks news story on Broadridge, Range Resources »

Broadridge to replace…

BR

Broadridge

$114.93

0.06 (0.05%)

RRC

Range Resources

$15.96

-0.19 (-1.18%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Aug

04:55
06/18/18
06/18
04:55
06/18/18
04:55
General news
Breaking General news story  »

Atlanta Federal Reserve…

04:55
06/18/18
06/18
04:55
06/18/18
04:55
General news
Breaking General news story  »

4-Week Bill Announcement…

VRX

Valeant

$26.86

0.06 (0.22%)

04:55
06/18/18
06/18
04:55
06/18/18
04:55
Conference/Events
Breaking Conference/Events news story on Valeant »

FDA PDUFA Date for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jun

  • 27

    Aug

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.